UBS Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $9.82M | Buy |
|
|||||
|
2024
Q3 | $2.11M | Buy |
|
|||||
|
2024
Q2 | $1.27M | Sell |
|
|||||
|
2024
Q1 | $2.19M | Buy |
|
|||||
|
2023
Q4 | $1.7M | Buy |
|
|||||
|
2023
Q3 | $510K | Sell |
|
|||||
|
2023
Q2 | $1.21M | Buy |
|
|||||
|
2023
Q1 | $1.42M | Sell |
|
|||||
|
2022
Q4 | $2.8M | Buy |
|
|||||
|
2022
Q3 | $470K | Sell |
|
|||||
|
2022
Q2 | $575K | Sell |
|
|||||
|
2022
Q1 | $4.24M | Buy |
|
|||||
|
2021
Q4 | $4.68M | Buy |
|
|||||
|
2021
Q3 | $2.87M | Buy |
|
|||||
|
2021
Q2 | $1.94M | Buy |
|
|||||
|
2021
Q1 | $577K | Buy |
|
|||||
|
2020
Q4 | $98K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $117K | Sell |
|
|||||
|
2020
Q1 | $173K | Sell |
|
|||||
|
2019
Q4 | $557K | Buy |
|
|||||
|
2019
Q3 | $184K | Buy |
|
|||||
|
2019
Q2 | $104K | Buy |
|
|||||
|
2019
Q1 | $44K | Sell |
|
|||||
|
2018
Q4 | $155K | Buy |
|
|||||
|
2018
Q3 | $209K | Buy |
|
|||||
|
2018
Q2 | $86K | Buy |
|
|||||
|
2018
Q1 | $8K | Sell |
|
|||||
|
2017
Q4 | $11K | Hold |
|
|||||
|
2017
Q3 | $9K | Sell |
|
|||||
|
2017
Q2 | $21K | Buy |
|
|||||
|
2017
Q1 | $21K | Buy |
|
|||||
|
2016
Q4 | $6K | Hold |
|
|||||
|
2016
Q3 | $9K | Sell |
|
|||||
|
2016
Q2 | $21K | Buy |
|
|||||
|
2016
Q1 | $18K | Sell |
|
|||||
|
2015
Q4 | $75K | Buy |
|
|||||
|
2015
Q3 | $37K | Sell |
|
|||||
|
2015
Q2 | $68K | Sell |
|
|||||
|
2015
Q1 | $74K | Sell |
|
|||||
|
2014
Q4 | $123K | Buy |
|